Latest News and Press Releases
Want to stay updated on the latest news?
-
CHICAGO, Nov. 23, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG), today announced an investor conference call to be held at 4:15 p.m. Eastern Daylight Savings Time on Wednesday,...
-
CHICAGO, Nov. 1, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) ("MDI") has entered into a major strategic alliance with the biotechnology division of a Fortune 500 healthcare company....
-
CHICAGO, Oct. 18, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) ("MDI") and its wholly owned subsidiary, AccuMed International, Inc. ("AccuMed") collectively ("MOI" Group), based in...
-
CHICAGO, Ill., Aug. 4, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) announced today that at its Annual Meeting of Shareholders held on July 29, 2004, the Company's shareholders...
-
CHICAGO, June 24, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) announced today that it has completed a $2,600,000 private placement of convertible notes. In addition, the Company...
-
CHICAGO, June 17, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) announced today that it will hold an investor conference call at 4:15 p.m. Eastern Daylight Savings Time on Thursday,...
-
CHICAGO, June 15, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) ("MDI") announced today that it has learned from the listing broker Berliner Freiverkehr AG that its common stock has...
-
CHICAGO, June 7, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) announced today that it has learned its common stock has been listed and traded on the Berlin-Bremen Stock Exchange...
-
CHICAGO, April 5, 2004 (PRIMEZONE) -- Molecular Diagnostics, Inc. (OTCBB:MCDG) ("MDI") announced today that it has received a $1.5 million investment transacted by Bathgate Capital Partners, LLC of...